Mirtrons in Human Cancers

Area of Science:

• Molecular Biology
• Genetics
• Cancer Research

Background:

• Mirtrons are a distinct subclass of microRNAs (miRNAs) processed via non-canonical biogenesis pathways, differing from canonical miRNAs that require Drosha cleavage.
• These small RNAs are generated from spliced intronic sequences, bypassing the Drosha processing step entirely.
• While mirtrons are conserved across species, they exhibit low evolutionary conservation, leading to species-specific regulatory functions, particularly in human cancer biology.

Purpose of the Study:

• To review the current understanding of mirtron biogenesis and their biological roles in cancer.
• To highlight the emerging evidence of mirtrons' critical involvement in various oncogenic processes.
• To explore the potential of mirtrons as biomarkers for cancer diagnosis/prognosis and as therapeutic targets in precision oncology.

Main Methods:

• Literature review of research on mirtron biogenesis and function.
• Analysis of studies investigating mirtron involvement in tumor initiation, progression, metastasis, and therapy resistance.
• Examination of recent advances in understanding mirtron regulatory mechanisms and clinical relevance.

Main Results:

• Mirtrons influence oncogenic processes by directly regulating oncogenes and tumor suppressor genes.
• Their unique biogenesis and structural attributes present alternative regulatory mechanisms in cancer.
• Emerging data indicates mirtrons' significant potential in cancer diagnostics, prognosis, and as therapeutic targets.

Conclusions:

• Mirtrons represent an understudied but crucial group of regulatory RNAs in human cancer.
• Their distinct features and functions offer novel insights into cancer biology.
• Further research into mirtrons holds promise for advancing cancer diagnostics and therapeutics.